Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
iRadimed
IRMD
$1.11B
| $2.64M | ﹤0.01% |
55,303
+9,469
| +21% | +$427K |
|
3177
Ardagh Metal Packaging
AMBP
$3.07B
| $2.64M | ﹤0.01% |
702,069
+548,540
| +357% | +$2.03M |
|
|
INST
3178
DELISTED
Instructure Holdings, Inc.
INST
| $2.64M | ﹤0.01% |
104,829
+16,833
| +19% | +$422K |
|
3179
CALL
Waste Management
WM
$87.8B
| $2.64M | ﹤0.01% |
15,200
-22,600
| -60% | -$3.74M |
|
3180
Stanley Black & Decker
SWK
$14.8B
| $2.63M | ﹤0.01% |
28,107
+4,026
| +17% | +$333K |
|
3181
Toyota
TM
$230B
| $2.63M | ﹤0.01% |
16,368
-7,940
| -33% | -$1.14M |
|
3182
Alkami Technology
ALKT
$2.16B
| $2.63M | ﹤0.01% |
160,453
+103,248
| +180% | +$1.42M |
|
|
DRD
3183
DRDGold
DRD
$2.5B
| $2.63M | ﹤0.01% |
247,583
+106,384
| +75% | +$1.21M |
|
3184
Werewolf Therapeutics
HOWL
$45.8M
| $2.62M | ﹤0.01% |
859,247
-238,101
| -22% | -$670K |
|
3185
Hope Bancorp
HOPE
$1.78B
| $2.61M | ﹤0.01% |
310,538
+32,121
| +12% | +$280K |
|
|
CNDA
3186
DELISTED
Concord Acquisition Corp II
CNDA
| $2.6M | ﹤0.01% |
253,739
| – | – |
|
|
FIRY
3187
Firy Inc
FIRY
$161M
| $2.6M | ﹤0.01% |
285,470
+192,136
| +206% | +$2.22M |
|
3188
Global X Copper Miners ETF NEW
COPX
$8.64B
| $2.6M | ﹤0.01% |
+68,968
| New | +$2.65M |
|
3189
CALL
uniQure
QURE
$3.38B
| $2.59M | ﹤0.01% |
+226,200
| New | +$4.29M |
|
3190
BlackBerry
BB
$4.78B
| $2.59M | ﹤0.01% |
+467,054
| New | +$2.26M |
|
3191
OptimizeRx
OPRX
$150M
| $2.58M | ﹤0.01% |
180,800
-149,563
| -45% | -$2.13M |
|
3192
NewMarket
NEU
$8.41B
| $2.57M | ﹤0.01% |
6,403
-6,120
| -49% | -$2.39M |
|
3193
Perella Weinberg Partners
PWP
$1.26B
| $2.57M | ﹤0.01% |
308,742
+158,249
| +105% | +$1.31M |
|
3194
Nektar Therapeutics
NKTR
$2.48B
| $2.57M | ﹤0.01% |
298,055
+294,305
| +7,848% | +$3.14M |
|
3195
CALL
Futu Holdings
FUTU
$17.4B
| $2.57M | ﹤0.01% |
+64,700
| New | +$2.75M |
|
3196
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.96B
| $2.57M | ﹤0.01% |
+28,575
| New | +$2.22M |
|
3197
PUT
Macy's
M
$5.79B
| $2.57M | ﹤0.01% |
160,100
-664,900
| -81% | -$10.6M |
|
3198
Verizon
VZ
$208B
| $2.57M | ﹤0.01% |
69,064
-2,665,999
| -97% | -$98.7M |
|
3199
Evotec
EVO
$679M
| $2.56M | ﹤0.01% |
228,954
-5,669
| -2% | -$60.5K |
|
3200
Ultragenyx Pharmaceutical
RARE
$2.52B
| $2.56M | ﹤0.01% |
55,445
-706,402
| -93% | -$32.8M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.